Release Date: 29/01/10 14:33 Summary: Quarterly Activities and Cshflow Report Price Sensitive: Yes Download Document 1.96MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%